Palisade Bio (PALI) Restructuring Costs (2013 - 2026)

Palisade Bio (PALI) has reported Restructuring Costs for 4 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Restructuring Costs rose 213.14% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $10.5 million (up 91.8% YoY), while the FY2025 annual figure was $7.6 million, up 38.37% from the prior year.
• Restructuring Costs improved to $4.2 million in Q1 2026 per PALI's latest filing, from $3.6 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $4.2 million in Q1 2026 and bottomed at $1.1 million in Q2 2025.
• Historically, Restructuring Costs has averaged $1.9 million across 3 years, with a median of $1.4 million in 2024.
• Annual changes were most pronounced in 2025 — Restructuring Costs fell 22.6% — and 2026, when it surged 213.14%.
• Palisade Bio's Restructuring Costs stood at $1.4 million in 2024, then soared by 158.13% to $3.6 million in 2025, then grew by 18.15% to $4.2 million in 2026.
• Business Quant data shows PALI's Restructuring Costs at $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $1.5 million in Q3 2025.